Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for Eteplirsen

September 19, 2016 9:51 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Sarepta Therapeutics (NASDAQ: SRPT) surges higher on FDA approval for eteplirsen

Letter from FDA

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Hot FDA News, Management Changes, Trader Talk

Add Your Comment